Skip to main content
. 2001 Apr;39(4):1247–1253. doi: 10.1128/JCM.39.4.1247-1253.2001

FIG. 3.

FIG. 3

(A) Seroprevalences of HTLV-1 and HGIP according to age among Guadeloupean blood donors (P = 0.03 between HTLV-1-positive and HGIP donors by WB2.4 [1993 to 1998]). (B) Seroprevalences of HTLV-1 and HGIP according to gender among Guadeloupean blood donors (P = 0.003 between HTLV-1-positive and HGIP donors by WB2.4 [1993 to 1998]). (C) Seroprevalences of HTLV-1 and HGIP according to HBc antibody positivity among Guadeloupean blood donors (P = 0.03 between HTLV-1-positive and HGIP donors by WB2.4 [1993 to 1998]). (D) Seroprevalences of HTLV-1 and HGIP according to HBc antibody positivity among Guadeloupean blood donors (P = 0.01 between HTLV-1-positive and HGIP donors by WB2.4 [1993 to 1998]).